Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 239136, 7 pages
http://dx.doi.org/10.1155/2015/239136
Research Article

Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients

1School of Geriatrics, University of Medicine, 10100 Turin, Italy
2Cardiovascular Rehabilitation-Heart Failure Unit, Ospedale SS Trinita, 12045 Fossano, Italy

Received 10 December 2014; Accepted 26 March 2015

Academic Editor: Kristin Eckardt

Copyright © 2015 Laura Leto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Yancy, M. Jessup, B. Bozkurt et al., “2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/american heart association task force on practice guidelines,” Journal of the American College of Cardiology, vol. 62, no. 16, pp. e147–e239, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Sachdeva, T. B. Horwich, and G. C. Fonarow, “Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure,” American Journal of Cardiology, vol. 106, no. 6, pp. 830–835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Bettencourt, A. Azevedo, J. Pimenta, F. Friões, S. Ferreira, and A. Ferreira, “N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients,” Circulation, vol. 110, no. 15, pp. 2168–2174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Sahn, A. DeMaria, J. Kisslo, and A. Weyman, “Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements,” Circulation, vol. 58, no. 6, pp. 1072–1083, 1978. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Garcia, J. D. Thomas, and A. L. Klein, “New doppler echocardiographic applications for the study of diastolic function,” Journal of the American College of Cardiology, vol. 32, no. 4, pp. 865–875, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, “ATS statement: guidelines for the six-minute walk test,” The American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 1, pp. 111–117, 2002. View at Google Scholar
  7. “Bioelectrical impedance analysis in body composition measurement. Proceedings of a National Institutes of Health Technology Assessment Conference. Bethesda, Md, USA, December 1994,” The American Journal of Clinical Nutrition, vol. 64, supplement, pp. 387S–532S, 1996.
  8. A. Piccoli, “Patterns of bioelectrical impedance vector analysis: learning from electrocardiography and forgetting electric circuit models,” Nutrition, vol. 18, no. 6, pp. 520–521, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. T. F. Katz, “A.D.L. Activities of daily living,” The Journal of the American Medical Association, vol. 185, pp. 914–919, 1963. View at Google Scholar
  10. F. I. Mahoney and D. W. Barthel, “Functional evaluation: the Barthel index,” Maryland State Medical Journal, vol. 14, pp. 61–65, 1965. View at Google Scholar · View at Scopus
  11. M. P. Lawton and E. M. Brody, “Assessment of older people: self-maintaining and instrumental activities of daily living,” Gerontologist, vol. 9, no. 3, pp. 179–186, 1969. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Google Scholar
  13. J. A. Yesavage, T. L. Brink, T. L. Rose et al., “Development and validation of a geriatric depression screening scale: a preliminary report,” Journal of Psychiatric Research, vol. 17, no. 1, pp. 37–49, 1982. View at Publisher · View at Google Scholar · View at Scopus
  14. T. S. Rector and J. N. Cohn, “Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan,” The American Heart Journal, vol. 124, no. 4, pp. 1017–1025, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. Green, A. Martinez-Rumayor, S. A. Gregory et al., “Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea,” Archives of Internal Medicine, vol. 168, no. 7, pp. 741–748, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. S. Vasan, E. J. Benjamin, M. G. Larson et al., “Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study,” Journal of the American Medical Association, vol. 288, no. 10, pp. 1252–1259, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Neuhold, M. Huelsmann, G. Strunk et al., “Comparison of copeptin, b-type natriuretic peptide, and amino-terminal pro-b-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease,” Journal of the American College of Cardiology, vol. 52, no. 4, pp. 266–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Bettencourt, A. Azevedo, J. Pimenta, F. Friões, S. Ferreira, and A. Ferreira, “N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients,” Circulation, vol. 110, no. 15, pp. 2168–2174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. G. C. Fonarow, W. F. Peacock, T. B. Horwich et al., “Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE,” The American Journal of Cardiology, vol. 101, no. 2, pp. 231–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Maisel, P. Krishnaswamy, R. M. Nowak et al., “Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure,” The New England Journal of Medicine, vol. 347, no. 3, pp. 161–167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Porapakkham, H. Zimmet, B. Billah, and H. Krum, “B-type natriuretic peptide-guided heart failure therapy: a meta-analysis,” Archives of Internal Medicine, vol. 170, no. 6, pp. 507–514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Felker, V. Hasselblad, A. F. Hernandez, and C. M. O'Connor, “Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials,” American Heart Journal, vol. 158, no. 3, pp. 422–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Pfisterer, P. Buser, H. Rickli et al., “BNP-guided vs symptom-guided heart failure therapy the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial,” Journal of the American Medical Association, vol. 301, no. 4, pp. 383–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. G. Lainchbury, R. W. Troughton, K. M. Strangman et al., “N-terminal pro- B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial,” Journal of the American College of Cardiology, vol. 55, no. 1, pp. 53–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. S. Dhaliwal, A. Deswal, A. Pritchett et al., “Reduction in BNP levels with treatment of decompensated heart failure and future clinical events,” Journal of Cardiac Failure, vol. 15, no. 4, pp. 293–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Jourdain, G. Jondeau, F. Funck et al., “Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. The STARS-BNP Multicenter Study,” Journal of the American College of Cardiology, vol. 49, no. 16, pp. 1733–1739, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. I. L. Gerber, R. A. H. Stewart, M. E. Legget et al., “Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis,” Circulation, vol. 107, no. 14, pp. 1884–1890, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Morello, D. M. Lloyd-Jones, C. U. Chae et al., “Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study,” American Heart Journal, vol. 153, no. 1, pp. 90–97, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Anwaruddin, D. M. Lloyd-Jones, A. Baggish et al., “Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP investigation of dyspnea in the emergency department (PRIDE) study,” Journal of the American College of Cardiology, vol. 47, no. 1, pp. 91–97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. J. Wang, M. G. Larson, D. Levy et al., “Impact of age and sex on plasma natriuretic peptide levels in healthy adults,” American Journal of Cardiology, vol. 90, no. 3, pp. 254–258, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Bayes-Genis, D. M. Lloyd-Jones, R. R. J. Van Kimmenade et al., “Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea,” Archives of Internal Medicine, vol. 167, no. 4, pp. 400–407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. L. B. Daniels, P. Clopton, V. Bhalla et al., “How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study,” American Heart Journal, vol. 151, no. 5, pp. 999–1005, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Kerola, T. Nieminen, S. Hartikainen, R. Sulkava, O. Vuolteenaho, and R. Kettunen, “B-type natriuretic peptide as a predictor of declining cognitive function and dementia—a cohort study of an elderly general population with a 5-year follow-up,” Annals of Medicine, vol. 42, no. 3, pp. 207–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. L. B. Daniels, G. A. Laughlin, D. Kritz-Silverstein et al., “Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults,” The American Journal of Medicine, vol. 124, no. 7, pp. 670e1–670e8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Gunstad, A. Poppas, S. Smeal et al., “Relation of brain natriuretic peptide levels to cognitive dysfunction in adults >55 years of age with cardiovascular disease,” The American Journal of Cardiology, vol. 98, no. 4, pp. 538–540, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Feola, G. L. Rosso, M. Peano et al., “Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure,” Archives of Medical Research, vol. 38, no. 2, pp. 234–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Leto and M. Feola, “Cognitive impairment in heart failure patients,” Journal of Geriatric Cardiology, vol. 11, no. 4, pp. 316–328, 2014. View at Google Scholar